BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/2/2022 9:49:51 AM | Browse: 238 | Download: 554
 |
Received |
|
2022-09-19 20:48 |
|
Peer-Review Started |
|
2022-09-19 20:50 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-10-19 03:12 |
|
Revised |
|
2022-10-26 14:51 |
|
Second Decision |
|
2022-11-14 03:27 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-11-17 17:29 |
|
Articles in Press |
|
2022-11-17 17:29 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-11-10 01:55 |
|
Typeset the Manuscript |
|
2022-11-23 10:14 |
|
Publish the Manuscript Online |
|
2022-12-02 09:49 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Review |
| Article Title |
Gastrointestinal microbiota: A predictor of COVID-19 severity?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Maria Adriana Neag, Damiana-Maria Vulturar, Diana Gherman, Codrin-Constantin Burlacu, Doina Adina Todea and Anca Dana Buzoianu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Damiana-Maria Vulturar, PhD, Doctor, Researcher, Department of Pneumology, Iuliu Hațieganu University of Medicine and Pharmacy, Victor Babes Street No. 8, Cluj-Napoca 400332, Romania. vulturar.damianamaria@elearn.umfcluj.ro |
| Key Words |
Gut microbiota; COVID-19; Prognostic biomarkers; Gut-lung axis; Probiotics; Nutraceuticals |
| Core Tip |
In the last 10 years, the intestinal microbiota has been intensively studied in relation to various diseases from gastrointestinal to cardiovascular, respiratory, and even neurological or psychiatric diseases. Coronavirus disease 2019 (COVID-19) has been a challenge in this regard. Thus, in this review we highlighted the link between microbiota and COVID-19, aspects of the clinical and imaging manifestation and the potential role of some nutraceuticals in this widespread respiratory viral disease. |
| Publish Date |
2022-12-02 09:49 |
| Citation |
Neag MA, Vulturar DM, Gherman D, Burlacu CC, Todea DA, Buzoianu AD. Gastrointestinal microbiota - a predictor of COVID-19 severity? World J Gastroenterol 2022; 28(45): 6328-6344 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i45/6328.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i45.6328 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
